BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 36219802)

  • 1. Longitudinal Effects of Combination Antiretroviral Therapy on Cognition and Neuroimaging Biomarkers in Treatment-Naive People With HIV.
    Weber MT; Finkelstein A; Uddin MN; Reddy EA; Arduino RC; Wang L; Tivarus ME; Zhong J; Qiu X; Schifitto G
    Neurology; 2022 Sep; 99(10):e1045-e1055. PubMed ID: 36219802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal Trajectories of Brain Volume and Cortical Thickness in Treated and Untreated Primary Human Immunodeficiency Virus Infection.
    Sanford R; Ances BM; Meyerhoff DJ; Price RW; Fuchs D; Zetterberg H; Spudich S; Collins DL
    Clin Infect Dis; 2018 Nov; 67(11):1697-1704. PubMed ID: 29697762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Framingham 10-Year Cardiovascular Risk Score and Viral Load on Brain Integrity in Persons With HIV.
    Glans M; Cooley SA; Vaida F; Boerwinkle A; Tomov D; Petersen KJ; Rosenow A; Paul RH; Ances BM
    J Acquir Immune Defic Syndr; 2022 May; 90(1):79-87. PubMed ID: 35067658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved induced innate immune response after cART initiation in people with HIV.
    Hove-Skovsgaard M; Møller DL; Hald A; Gerstoft J; Lundgren J; Ostrowski SR; Nielsen SD
    Front Immunol; 2022; 13():974767. PubMed ID: 36059528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multimodal Investigation of Neuroinflammation in Aviremic Patients With HIV on Antiretroviral Therapy and HIV Elite Controllers.
    Sari H; Galbusera R; Bonnier G; Lin Y; Alshelh Z; Torrado-Carvajal A; Mukerji SS; Ratai EM; Gandhi RT; Chu JT; Akeju O; Orhurhu V; Salvatore AN; Sherman J; Kwon DS; Walker B; Rosen B; Price JC; Pollak LE; Loggia ML; Granziera C
    Neurol Neuroimmunol Neuroinflamm; 2022 Mar; 9(2):. PubMed ID: 35140142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regionally Specific Brain Volumetric and Cortical Thickness Changes in HIV-Infected Patients in the HAART Era.
    Sanford R; Fernandez Cruz AL; Scott SC; Mayo NE; Fellows LK; Ances BM; Collins DL
    J Acquir Immune Defic Syndr; 2017 Apr; 74(5):563-570. PubMed ID: 28129254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Brain Structure Changes and Cognitive Function With Combination Antiretroviral Therapy in HIV-Positive Individuals.
    Sanford R; Fellows LK; Ances BM; Collins DL
    JAMA Neurol; 2018 Jan; 75(1):72-79. PubMed ID: 29131878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered brain morphometry in 7-year old HIV-infected children on early ART.
    Nwosu EC; Robertson FC; Holmes MJ; Cotton MF; Dobbels E; Little F; Laughton B; van der Kouwe A; Meintjes EM
    Metab Brain Dis; 2018 Apr; 33(2):523-535. PubMed ID: 29209922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Redistribution of brain glucose metabolism in people with HIV after antiretroviral therapy initiation.
    Wang Z; Manion MM; Laidlaw E; Rupert A; Lau CY; Smith BR; Nath A; Sereti I; Hammoud DA
    AIDS; 2021 Jul; 35(8):1209-1219. PubMed ID: 33710014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination antiretroviral therapy improves cognitive performance and functional connectivity in treatment-naïve HIV-infected individuals.
    Zhuang Y; Qiu X; Wang L; Ma Q; Mapstone M; Luque A; Weber M; Tivarus M; Miller E; Arduino RC; Zhong J; Schifitto G
    J Neurovirol; 2017 Oct; 23(5):704-712. PubMed ID: 28791662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial toxicity before and after combination antiretroviral therapy, a Magnetic Resonance Spectroscopy study.
    Tivarus ME; Zhuang Y; Wang L; Murray KD; Venkataraman A; Weber MT; Zhong J; Qiu X; Schifitto G
    Neuroimage Clin; 2021; 31():102693. PubMed ID: 34020161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in Hepatocellular Carcinoma Incidence and Risk Among Persons With HIV in the US and Canada, 1996-2015.
    Sun J; Althoff KN; Jing Y; Horberg MA; Buchacz K; Gill MJ; Justice AC; Rabkin CS; Goedert JJ; Sigel K; Cachay E; Park L; Lim JK; Kim HN; Lo Re V; Moore R; Sterling T; Peters MG; Achenbach CJ; Silverberg M; Thorne JE; Mayor AM; Crane HM; Kitahata MM; Klein M; Kirk GD;
    JAMA Netw Open; 2021 Feb; 4(2):e2037512. PubMed ID: 33595662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blunted response to combination antiretroviral therapy in HIV elite controllers: an international HIV controller collaboration.
    Boufassa F; Lechenadec J; Meyer L; Costagliola D; Hunt PW; Pereyra F; Deeks S; Pancino G; Taulera O; Lichterfeld M; Delobel P; Saez-Cirion A; Lambotte O; ; ; ;
    PLoS One; 2014; 9(1):e85516. PubMed ID: 24465584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurocognitive Dysfunction With Neuronal Injury in People With HIV on Long-Duration Antiretroviral Therapy.
    McMahan C; Dietrich DK; Horne EF; Kelly E; Geannopoulos K; Siyahhan Julnes PS; Ham L; Santamaria U; Lau CY; Wu T; Hsieh HC; Ganesan A; Berjohn C; Kapetanovic S; Reich DS; Nair G; Snow J; Agan BK; Nath A; Smith BR
    Neurology; 2023 Jun; 100(24):e2466-e2476. PubMed ID: 37105760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of HIV and combination antiretroviral therapy on cortico-striatal functional connectivity.
    Ortega M; Brier MR; Ances BM
    AIDS; 2015 Mar; 29(6):703-12. PubMed ID: 25849834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood-Brain Barrier Disruption Is Initiated During Primary HIV Infection and Not Rapidly Altered by Antiretroviral Therapy.
    Rahimy E; Li FY; Hagberg L; Fuchs D; Robertson K; Meyerhoff DJ; Zetterberg H; Price RW; Gisslén M; Spudich S
    J Infect Dis; 2017 Apr; 215(7):1132-1140. PubMed ID: 28368497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of age, HIV, and HIV-associated clinical factors on neuropsychological functioning and brain regional volume in HIV+ patients on effective treatment.
    Gawron N; Choiński M; Szymańska-Kotwica B; Pluta A; Sobańska M; Egbert AR; Desowska A; Wolak T; Horban A; Firląg-Burkacka E; Bieńkowski P; Sienkiewicz-Jarosz H; Scińska-Bieńkowska A; Biswal B; Rao SM; Bornstein R; Łojek E
    J Neurovirol; 2019 Feb; 25(1):9-21. PubMed ID: 30298203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble biomarkers of immune activation and inflammation in HIV infection: impact of 2 years of effective first-line combination antiretroviral therapy.
    Hattab S; Guiguet M; Carcelain G; Fourati S; Guihot A; Autran B; Caby F; Marcelin AG; Costagliola D; Katlama C
    HIV Med; 2015 Oct; 16(9):553-62. PubMed ID: 25944318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive and Neuronal Link With Inflammation: A Longitudinal Study in People With and Without HIV Infection.
    Anderson AM; Jang JH; Easley KA; Fuchs D; Gisslen M; Zetterberg H; Blennow K; Ellis RJ; Franklin D; Heaton RK; Grant I; Letendre SL
    J Acquir Immune Defic Syndr; 2020 Dec; 85(5):617-625. PubMed ID: 32932412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma Levels of C-Type Lectin REG3α and Gut Damage in People With Human Immunodeficiency Virus.
    Isnard S; Ramendra R; Dupuy FP; Lin J; Fombuena B; Kokinov N; Kema I; Jenabian MA; Lebouché B; Costiniuk CT; Ancuta P; Bernard NF; Silverman MS; Lakatos PL; Durand M; Tremblay C; Routy JP;
    J Infect Dis; 2020 Jan; 221(1):110-121. PubMed ID: 31504638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.